75 -5 (55) 2023 — Azizov B.S., Latipov I.I. — THE RESULTS OF THE CLINICAL EFFECTIVENESS OF THE TREATMENT OF PATIENTS WITH VITILIGO AS A RESULT OF TREATMENT WITH THE DEVELOPED MODIFIED IMMUNOCORRECTIVE COMPLEX THERAPY

THE RESULTS OF THE CLINICAL EFFECTIVENESS OF THE TREATMENT OF PATIENTS WITH VITILIGO AS A RESULT OF TREATMENT WITH THE DEVELOPED MODIFIED IMMUNOCORRECTIVE COMPLEX THERAPY

Azizov B.S., Bukhara State Medical Institute named after Abu Ali ibn Sina, Tashkent State Dental Institute.

Latipov I.I. Bukhara State Medical Institute named after Abu Ali ibn Sina, Tashkent State Dental Institute.

Resume

For the period from 2020 to 2023, 118 patients (Group I (main group) n=60, Group II (comparison group) n=58) from patients with two clinical forms of vitiligo were examined. The control group for immunological studies consisted of 20 healthy donors. The study included patients of both sexes: 66 women and 52 men, aged 18 to 75 years (mean age 38.5 ± 6.8 years). Complete clinical improvement (repigmentation ≥96% ), complete clinical remission in Group I patients who used the modified immunocorrective complex therapy developed by us with the inclusion of pentaxophylline and dexamethasone was achieved in 53 patients (44.9%), and in Group II patients who did not use immunocorrective therapy, only 34 (28.8%) patients with vitiligo.

Keywords: vitiligo, immunocorrective complex therapy, excimer laser, UVB therapy

First page

426

Last page

432

For citation: Azizov B.S., Latipov I.I. – THE RESULTS OF THE CLINICAL EFFECTIVENESS OF THE TREATMENT OF PATIENTS WITH VITILIGO AS A RESULT OF TREATMENT WITH THE DEVELOPED MODIFIED IMMUNOCORRECTIVE COMPLEX THERAPY //New Day in Medicine 2023 5(55): 426-432 https://newdaymedicine.com/index.php/2023/06/12/l-124/

LIST OF REFERENCES:

1. Абдуллаев М.И., Шадыев Х.К., Сулейманов К.С., Ахмедов К.Р. Витилиго Вестн. дерматол. и венерол.  1992 4:28-33.
2. Арифов С.С., Ваисов А.Ш. Роль катехоламинов и перекисного окисления липидов в патогенезе витилиго Вестн. дермат. 1994 3:25-27.
3. Ваисов А.Ш., Байбеков И.М., Хорошаева В. А. и др. Иммуноморфология кожи при витилиго Сб. науч. ст. и тез. Докладов Пленума Правления ВНМОДВ. 1988 166-167.
4. Васильченко Т.С., Габдракипова А.А., Белянская И.А. Этиопатогенез и диагностика витилиго Синергия Наук. 2019 31:1434-1437.
5. Круглова Л.С. Витилиго: Современные взгляды на этиологию, патогенез и методы лечения. Российский журнал кожных и венерических болезней. 2016  19(4):241-244.
6. Лoмoнoсoв К.М., Мирoнoв A.Ю., Кузнeцoв O.В., БaбeшкoO.A. Рoль вирусoв в пaтoгeнeзe витилигo  Рoс.журн. кoжн. и вeнeрич. бoл. 2012 40-42.
7. Maxmudov F.A., Latipov I.I., Ozodov J.H., Yusupov D.A., Vitiligo extent tensity index (veti) score: a new definition, assessment and treatment evaluation criteria in vitiligo New Day in Medicine 2020 1(29):268-271 https://newdaymedicine.com/index.php/2020/04/09/73-1-29-2-2020
8. Latipov I.I., Efficacy of metotrexate in treatment of vitiligo New Day in Medicine 2020 4(32):556-559 https://newdaymedicine.com/index.php/2021/01/13
9. Maxmudov F.A., Latipov I.I. The immunopathogenesis of atopic dermatitis and strategy of immunotherapy New Day Medicine 2019 4(28):53-56 https://newdaymedicine.com/index.php/2020/01/08/11-4-28-1-2019
10. Прoшутинскaя Д.В. Витилигo.  Дeрмaтoвeнeрoлoгия: Клин, рeкoмeндaции /Пoд рeд. A.A. Кубaнoвoй. М.: ГЭOТAР-Мeдиa, 2006. С. 116-126.
11. Прошутинская Д.В., Волнухин В.А., Жилова М.Б., Борова О.В. Эффективность терапии больных витилиго ультрафиолетовым эксимерным лазером Вестник дерматологии и венерологии. 2009 4:68-73.
12. Шарафутдинова Л.А. Клинико-иммунологическое обоснование патогенетической терапии сегментарного витилиго: автореф. Дис канд. мед. наук. – М., 2016 22.
13. Abd El-Samad Z., Shaaban D. Treatment of localized non-segmental vitiligo with intradermal 5-flurouracil injection combined with narrow-band ultraviolet B: a preliminary study  J. Dermatol. Treat. 2012 23(6):443-8. doi: 10.3109/09546634.2011.579084.
14. Abdurakhmanov M.M., Latipov I.I. – Immune aspects of vitiligo pathogenesis and treatment New Day in Medicine 2023 2(52):280-283 https:goo.su/08JDZy
15. Akdeniz N., Yavuz I.H., Gunes Bilgili S., Ozaydin Yavuz G., Calka O. Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasone and calcipotriol in vitiligo. J Dermatolog Treat. 2014 25(3):196-199. doi: 10.3109/09546634.2013.777381.
16. Aubin F., Vigan M., Puzenat E., Blanc D., Drobacheff C., Deprez P., Humbert P., Laurent R. Evaluation of a novel 308-nm monochromatic eximer light delivery system in dermatology: a pilot study in different chronic localized dermatoses.  Br J Dermatol. 2005 Jan 152(1):99-103.
17. Casacci M., Thomas P., Pacifico A. et al. Comparison between 308- nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo – a multicentre controlled study  J. Eur. Acad. Dermatol. Venereol. 2007 21(7):956-963.
18. Do J.E., Shin J.Y., Kim D.Y., Hann S.K., Oh S.H. The effect of 308nm excimer laser on segmental vitiligo: a retrospective study of 80 patients with segmentalvitiligo  Photodermatol Photoimmunol Photomed. 2011 27(3):147-51. doi: 10.1111/j.1600- 0781.2011.00587.x.
19. Edwards C. Measurement of vitiligo: human vs. MachineBr. J. Dermatol. 2019 180(5):991.
20. El Mofty M., Mostafa W., Esmat S., Youssef R., Az zam O., Hunter N., El Hanafi G., Fawzi M. Narrow band Ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies. Photodermatol Photoimmunol Photomed. 2006 Feb 22(1):6-11.